- Home
- SLGL vs TOI Comparison
SLGL vs TOI Comparison
Compare SLGL & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLGL
- TOI
- Stock Information
- Founded
- SLGL 1997
- TOI 2007
- Country
- SLGL Israel
- TOI United States
- Employees
- SLGL N/A
- TOI N/A
- Industry
- SLGL Biotechnology: Pharmaceutical Preparations
- TOI Medical/Nursing Services
- Sector
- SLGL Health Care
- TOI Health Care
- Exchange
- SLGL Nasdaq
- TOI Nasdaq
- Market Cap
- SLGL 18.3M
- TOI 15.5M
- IPO Year
- SLGL 2018
- TOI N/A
- Fundamental
- Price
- SLGL $0.43
- TOI $0.21
- Analyst Decision
- SLGL Strong Buy
- TOI Strong Buy
- Analyst Count
- SLGL 2
- TOI 1
- Target Price
- SLGL $5.00
- TOI $2.50
- AVG Volume (30 Days)
- SLGL 53.9K
- TOI 3.0M
- Earning Date
- SLGL 11-15-2024
- TOI 11-13-2024
- Dividend Yield
- SLGL N/A
- TOI N/A
- EPS Growth
- SLGL N/A
- TOI N/A
- EPS
- SLGL N/A
- TOI N/A
- Revenue
- SLGL $11,707,000.00
- TOI $378,933,000.00
- Revenue This Year
- SLGL $500.51
- TOI $29.17
- Revenue Next Year
- SLGL N/A
- TOI $16.43
- P/E Ratio
- SLGL N/A
- TOI N/A
- Revenue Growth
- SLGL 869.93
- TOI 22.29
- 52 Week Low
- SLGL $0.33
- TOI $0.13
- 52 Week High
- SLGL $1.58
- TOI $2.50
- Technical
- Relative Strength Index (RSI)
- SLGL 33.32
- TOI 49.25
- Support Level
- SLGL $0.44
- TOI $0.17
- Resistance Level
- SLGL $0.51
- TOI $0.24
- Average True Range (ATR)
- SLGL 0.04
- TOI 0.04
- MACD
- SLGL -0.01
- TOI 0.00
- Stochastic Oscillator
- SLGL 11.69
- TOI 29.47
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline consists of silica-based microencapsulation technology platform, and several generic product candidates across multiple indications.
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services.